89zr-j591
mAbexperimentalImaging agent
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2012 (NCT01543659)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Glutamate carboxypeptidase IIRadiopharmaceutical
FOLH1 radiopharmaceutical
Chemistry & pharmacology
- Multi-specific
- No
- Imaging
- 89-Zirconium
Oral
No
Parenteral
No
Topical
No
Also known as
- 89zr-dfo-huj591
- 89zr-j591
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02693860 | Phase 1 | Jan 1, 2016 | Cornell University |
| NCT02410577 | N/A | Apr 1, 2015 | Cornell University |
| NCT01543659 | Phase 1/Phase 2 (Phase 2) | Feb 1, 2012 | Broad Institute, Cornell University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cornell University | Academic/Hospital | 3 | 3 | 3 | 2012 |
| Broad Institute | Academic/Hospital | 1 | 0 | 1 | 2012 |
2 organizations
Page 1 / 1